Invivyd, Inc. (IVVD)
0.6636
+0.06
(+9.18%)
USD |
NASDAQ |
Oct 15, 16:00
0.679
+0.02
(+2.32%)
After-Hours: 20:00
Invivyd Profit Margin (Quarterly) : -310.8% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -310.8% |
| March 31, 2026 | -301.2% |
| December 31, 2025 | -64.33% |
| September 30, 2025 | -79.75% |
| June 30, 2025 | -124.4% |
| Date | Value |
|---|---|
| March 31, 2025 | -144.1% |
| December 31, 2024 | -133.5% |
| September 30, 2024 | -653.1% |
| June 30, 2024 | -2.09K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Agenus, Inc. | -1.64% |
| Amgen, Inc. | 23.59% |
| Anika Therapeutics, Inc. | 10.15% |
| BioCryst Pharmaceuticals, Inc. | 35.92% |
| Imunon, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -70.47% |
| Return on Assets | -55.57% |
| Return on Invested Capital | -68.22% |
| Gross Profit Margin (Quarterly) | 86.62% |
| Operating Margin (Quarterly) | -320.8% |
| Return on Net Operating Assets | -402.7% |